David A. Rosa - 14 Feb 2025 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Reporting relationship: Director
Issuer ticker: BRTX
Reported as of: 14 Feb 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 Feb 2025, 16:33:37 UTC
Prior SEC filing: 04 Feb 2025
Next SEC filing: 20 Feb 2025
Source filing: View source filing
Reporting owner signature: /s/ David Rosa

Key filing fact

David A. Rosa filed Form 4 for BioRestorative Therapies, Inc. (BRTX) on 19 Feb 2025.

Key facts

This page summarizes David A. Rosa's Form 4 filing for BioRestorative Therapies, Inc. (BRTX).
1 reported transaction and 4 derivative rows are listed below.
Accepted by SEC: 19 Feb 2025, 16:33.

Change

Previous filing in this sequence was filed on 04 Feb 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BRTX transaction Derivative

Stock Option

Award

Transaction value: $0
Shares: +52,632
Change %
Price: $0.000000
Shares after: 52,632
Date: 14 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 52,632
Exercise price: $2.46
Footnotes: F2

BRTX holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 10,490
Date: 14 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,490
Exercise price: $5.08
Footnotes: F1

BRTX holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 32,028
Date: 14 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 32,028
Exercise price: $2.91
Footnotes: F1

BRTX holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 79,646
Date: 14 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 79,646
Exercise price: $1.45
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The option is currently exercisable.

Footnote F2

The option vests and becomes exercisable in twelve nearly equal monthly installments of 4,386 shares beginning on March 14, 2025 and continuing every month thereafter until fully vested.